Wird geladen...
Improving siRNA Delivery In Vivo Through Lipid Conjugation
RNA interference (RNAi)-based therapeutics are approaching clinical approval for genetically defined diseases. Current clinical success is a result of significant innovations in the development of chemical architectures that support sustained, multi-month efficacy in vivo following a single administ...
Gespeichert in:
| Veröffentlicht in: | Nucleic Acid Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Mary Ann Liebert, Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994667/ https://ncbi.nlm.nih.gov/pubmed/29746209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0725 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|